To all our CKB CORE users, don’t miss the latest new features now available! Register for a free CORE account here and then login for access. Feel free to contact us at ckbsupport@genomenon.com if you have any questions!

Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02866747
Title A Study Evaluating the Association of Hypofractionated Stereotactic Radiation Therapy and Durvalumab for Patients With Recurrent Glioblastoma (STERIMGLI)
Acronym STERIMGLI
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Institut Claudius Regaud
Indications
Therapies
Age Groups: senior | adult
Covered Countries FRA


No variant requirements are available.